drugset / Trial / NCT01462435

Study of Diclofenac Capsules to Treat Pain Following Bunionectomy

NCT01462435

Phase 3 Completed 428 enrolled Iroko Pharmaceuticals, LLC
RandomizedParallel-groupTriple-blindTreatment

Summary

The purpose of this study is to determine whether Diclofenac \[Test\] Capsules are safe and effective for the treatment of bunionectomy pain.

Timeline

Start
2011-10
Primary completion
2012-02
Completion
2012-08

Drugs

EvaluationDrugModalityDoseRoute
Comparator Celecoxib Other / unclassified 200 mg
Subject Diclofenac Other / unclassified 18 mg
Subject Diclofenac Other / unclassified 35 mg

Indications

No indication recorded.